A Study of ASP1941 in Participants With Type 2 Diabetes Mellitus

A Study of ASP1941 in Japanese Patients With Type 2 Diabetes Mellitus

NCT01023945 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Pioglitazone in Type 2 Diabetic Patients

NCT01225081 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess Safety and Efficacy of ASP1941 in Combination With Nateglinide in Type 2 Diabetic Patients

NCT01316107 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Safety and Efficacy of ASP1941 in Combination With Dipeptidyl Peptidase-4 (DPP-4) Inhibitor in Type 2 Diabetic Patients

NCT01242228 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Safety and Tolerability of ASP1941 in Adults With Type 2 Diabetes Mellitus.

NCT00790660 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus

NCT01071850 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Sulfonylurea in Type 2 Diabetic Patients

NCT01242215 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Efficacy and Safety of Ipragliflozin in Combination With Insulin in Subjects With Type 2 Diabetes Mellitus

NCT02175784 ·Status: COMPLETED ·Phase: PHASE4

Study of Ipragliflozin in Patients With Type 2 Diabetes Mellitus Receiving Insulin Therapy

NCT02847091 ·Status: COMPLETED ·Phase: PHASE4

A Study of ASP1941 in Combination With Insulin in Patients With Type 1 Diabetes Mellitus

NCT02897219 ·Status: COMPLETED ·Phase: PHASE3

Post-Marketing Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Ipragliflozin in Combination With GLP-1 Receptor Agonists in Japanese Patients With Type 2 Diabetes Mellitus (T2DM)

NCT02291874 ·Status: COMPLETED ·Phase: PHASE4

A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes Mellitus

NCT01514838 ·Status: TERMINATED ·Phase: PHASE3

Specified Drug Use Results Survey of Ipragliflozin Treatment in type2 Diabetes Patients

NCT02479399 ·Status: COMPLETED

Pharmacodynamics, Pharmacokinetics, and Safety of ASP1941 in Patients With Type 1 Diabetes Mellitus

NCT02529449 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess Safety, Tolerability, and Pharmacokinetics of AZD0186

NCT05694741 ·Status: TERMINATED ·Phase: PHASE1

A Study to Assess Drug-Drug Interaction Between ASP1941 and Miglitol

NCT01099839 ·Status: COMPLETED ·Phase: PHASE1

A Study to Investigate Multiple Ascending Doses of AZD5004 in Healthy Japanese Participants and Participants With Type 2 Diabetes Mellitus

NCT06703658 ·Status: COMPLETED ·Phase: PHASE1

Evaluate Efficacy and Safety in Japanese Subjects With Type 2 Diabetes Mellitus

NCT01294423 ·Status: COMPLETED ·Phase: PHASE3

Evaluate Safety as Mono or Combination Therapies With Anti-diabetes Mellitus Drugs in Japanese Subjects With Type 2 Diabetes Mellitus

NCT01294436 ·Status: COMPLETED ·Phase: PHASE3

Phase III Insulin Add-On Asia Regional Program - ST

NCT02096705 ·Status: COMPLETED ·Phase: PHASE3

Trial to Evaluate the Efficacy and Safety of Dapagliflozin in Japanese Type 2 Diabetes Mellitus Patients

NCT00972244 ·Status: COMPLETED ·Phase: PHASE2

To Study Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1656 in Japanese Type 2 Diabetes Mellitus (T2DM) Patients

NCT00916604 ·Status: COMPLETED ·Phase: PHASE1

Phase IV Study With a 36-week Extension Period to Evaluate the Efficacy and Safety of Dapagliflozin Therapy When Added to the Therapy of Japanese Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin.

NCT02157298 ·Status: COMPLETED ·Phase: PHASE4

To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of Metformin

NCT00774553 ·Status: COMPLETED ·Phase: PHASE1

Double-blind Ipragliflozin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Sitagliptin (MK-0431J-843)

NCT02577003 ·Status: COMPLETED ·Phase: PHASE3